Equities

Joint Corp

JYNT:NAQ

Joint Corp

Actions
Health CareHealth Care Providers
  • Price (USD)11.90
  • Today's Change0.43 / 3.75%
  • Shares traded40.81k
  • 1 Year change+23.19%
  • Beta1.5730
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Joint Corp. is an operator, manager and franchisor of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment is comprised of the operating activities of the Company-owned or managed clinics. The Company operates or manages approximately 135 clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The franchise system consists of approximately 800 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

  • Revenue in USD (TTM)120.07m
  • Net income in USD-14.41m
  • Incorporated2010
  • Employees444.00
  • Location
    Joint Corp16767 N PERIMETER DRIVE, SUITE 240SCOTTSDALE 85260United StatesUSA
  • Phone+1 (480) 245-5960
  • Fax+1 (480) 513-7989
  • Websitehttps://www.thejoint.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cardiff Lexington Corp10.50m1.17m91.14m10.000.6132--76.418.6811.426.772.440.76780.5159--0.87481,050,259.009.67-18.6725.68--69.3862.0118.74-23.33--2.950.4169--10.8539.71164.24------
Zomedica Corp26.08m-55.99m124.94m144.00--0.5986--4.79-0.0571-0.05710.02660.2130.10541.7912.84181,090.30-22.64-14.03-23.35-14.4568.70---214.70-220.9810.68--0.00--33.05---102.93--89.85--
Nutex Health Inc275.93m-37.89m125.93m800.00--1.98--0.4564-8.45-8.4558.9112.580.642785.574.71344,910.60-6.93-69.35-8.57-84.8519.2110.97-10.79-102.851.550.93750.7683--12.93428.2289.22------
American Oncology Network Inc1.46bn-16.08m132.92m1.53k------0.0911-1.95-1.9591.571.873.5228.8310.64956,595.40-19.18---39.16--4.99---5.45--1.09-10.850.6438--11.27----------
DLH Holdings Corp401.04m2.47m139.56m3.20k63.501.297.130.3480.1550.15527.497.661.17--6.35125,324.400.72285.380.89847.2020.4420.560.61673.41--1.490.5970.00-4.8823.05-93.73-28.16-0.903--
American Well Corp254.91m-307.03m147.36m1.10k--0.404--0.5781-21.21-21.2117.5324.330.398323.784.10230,897.60-48.15-28.25-60.44-32.6634.2040.51-120.89-121.273.16--0.00---6.5517.85-149.66--51.49--
Longduoduo Co Ltd8.78m1.77m158.12m--89.23397.2876.3118.020.05910.05910.29230.01335.06453.60134.94--114.14------95.04--22.55--1.04--0.00--17.93--99.48------
23andMe Holding Co.199.19m-631.48m169.72m560.00--1.18--0.852-1.31-1.310.41120.28360.32158.2876.27355,692.80-101.91---130.54--44.7946.35-317.03-121.631.43--0.00---26.66-13.01-113.92---19.09--
Joint Corp120.07m-14.41m172.01m444.00--7.40--1.43-0.9743-0.97438.071.551.32--33.77270,430.40-15.864.32-23.506.0590.8290.28-12.003.68--1,156.170.0022--16.2426.27-1,656.09--35.09--
ModivCare Inc2.77bn-160.74m192.24m21.20k--20.23--0.0693-11.31-11.31195.280.66751.60--7.57130,778.60-9.06-1.36-13.29-1.8315.7317.58-5.66-0.9619--0.39780.9919--9.8514.71-542.83--19.27--
Biodesix Inc60.90m-44.51m252.61m217.00--6.97--4.15-0.4613-0.46130.61440.24980.6296--8.55280,654.40-46.01-55.60-60.16-80.9477.5859.53-73.08-105.15---3.610.4971--28.4619.1620.32--106.31--
Airsculpt Technologies Inc193.03m-3.42m255.13m346.00--3.0033.071.32-0.0619-0.06193.361.480.9033--62.36557,875.80-1.60---1.81--65.39---1.77----2.620.4541--16.07--69.49------
Data as of Sep 19 2024. Currency figures normalised to Joint Corp's reporting currency: US Dollar USD

Institutional shareholders

53.66%Per cent of shares held by top holders
HolderShares% Held
Bandera Partners LLCas of 30 Jun 20243.94m26.25%
The Vanguard Group, Inc.as of 30 Jun 2024981.38k6.54%
BlackRock Fund Advisorsas of 30 Jun 2024747.54k4.99%
Skylands Capital LLCas of 30 Jun 2024632.71k4.22%
Renaissance Technologies LLCas of 30 Jun 2024394.48k2.63%
Goldman Sachs Asset Management LPas of 30 Jun 2024293.48k1.96%
SSgA Funds Management, Inc.as of 30 Jun 2024288.63k1.93%
Geode Capital Management LLCas of 30 Jun 2024288.54k1.92%
D. E. Shaw & Co. LPas of 30 Jun 2024273.84k1.83%
First Foundation Advisorsas of 30 Jun 2024209.30k1.40%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.